Q: What did one chair say to another chair?
A: "Here comes another a**hole."
Genetic engineering patentsIn 1987, patents on genetic engineering patents were first authorized by the U.S. government, the first nation in the world to allow such patent applications. One year later, the first such patent was issued in the U.S. for a mouse designed to be highly susceptible to breast cancer. Designated as "oncomice," they were intended for use in testing anticancer therapies with more efficiency and accurate results. Geneticists Philip Leder and Timothy A. Stewart of Harvard University, Mass., developed the oncomouse, the patent was issued to the University, and commercial rights were assigned to E.I. du Pont de Nemours and Co., Del. The initial price of the oncomouse was $50 each. |
